Aducanumab is a medicine to treat Alzheimer’s disease by Biogen. The U.S. Food and Drug Administration (FDA) granted the priority review of aducanumab in August 2020. The FDA also set a start date for the Prescription Drug User Fee Act of 7 March 2021. Currently, the review is in progress.
Coronavirus disease (COVID-19) is a recently discovered infectious viral disease. Coronavirus causes it, and most people infected with the COVID-19 virus will experience mild to moderate respiratory distress and recover without needing advanced medical care. It was believed that aged people are most likely to experience severe illnesses. People with
Ginger and turmeric have been in use for many health conditions since ancient times. They have potent anti-inflammatory properties and are rich in many vital nutrients. Originating from the Zingiberaceae family both can be classified as rhizomes. What is rhizome? The rhizome is a stem that is later modified into